RTI: How did you become involved in the Global Network?
Dr. Mwenechanya: I began collaborating with the Global Network as a study physician during the BRAIN and Complimentary Feeding studies 7 years ago. I became interested in the community engagement and research concept behind the work, and over time became an integral part of the Zambia GN03 team as the Study Coordinator.
How have you seen the network develop over the last 7 years?
Dr. Mwenechanya: The most significant change of the trials to be from lower level studies to doing clinical trials. The Global Network hit the clinical trials world by storm, beginning with the first publication of ASPIRIN in The Lancet! As the lead site for the latest A-PLUS Study, we are looking forward to seeing the progress and outcomes of this new trial and its contribution to the standard of maternal and neonatal care worldwide.